Effectiveness of endocrine therapy for breast cancer in men
What The Study Did:
This randomized clinical trial looked at changes in levels of the hormone estradiol in men with hormone receptor-positive breast cancer after three months of treatment with endocrine therapies.
Authors:
Sibylle Loibl, M.D., Ph.D., of the German Breast Group in Neu-Isenburg, Germany, is the corresponding author.
To access the embargoed study:
Visit our For The Media website at this link
https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2020.7442)
Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
This randomized clinical trial looked at changes in levels of the hormone estradiol in men with hormone receptor-positive breast cancer after three months of treatment with endocrine therapies.
Authors:
Sibylle Loibl, M.D., Ph.D., of the German Breast Group in Neu-Isenburg, Germany, is the corresponding author.
To access the embargoed study:
Visit our For The Media website at this link
https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2020.7442)
Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media advisory:
The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article
This link will be live at the embargo time
https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.7442?guestAccessKey=32dca14c-423c-4b79-af71-12de4d1590b9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=020421